Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 1/2019

01-01-2019 | Stem Cell Transplantion | Review Article

Highlights of Abstracts on Hematopoietic Stem Cell Transplant in Annual Conference of ISHBT 2018

Authors: Preethi Jeyaraman, Rahul Naithani

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 1/2019

Login to get access

Abstract

Stem cell transplant in India has been seeing a steady progressive growth over the last decade. Thirty abstracts related to various aspects of bone marrow transplant were presented in the annual conference of Indian Society of Hematology and Transfusion medicine in 2018. All abstracts which were published were reviewed. They were categorized into autologous transplants, allogeneic transplants, lab aspects and supportive care. They have been summarized to provide a snapshot of the data presented. These data are likely to encourage to start or enhance transplant activity at other centers.
Literature
1.
go back to reference Naithani R (2018) Hematopoietic stem cell transplantation in India-2017 annual update. Indian J Hematol Blood Transfus 34(1):5–7CrossRefPubMed Naithani R (2018) Hematopoietic stem cell transplantation in India-2017 annual update. Indian J Hematol Blood Transfus 34(1):5–7CrossRefPubMed
2.
go back to reference Modak K, Radhakrishnan V, Lama M, Kathrotiya M, Bhave JS, Kumar J et al (2018) Outcomes of consolidation with R-BEAM high dose chemoimmunotherapy and autologous hematopoietic cell rescue in high risk B-cell lymphoma: a tertiary care single center experience. Indian J Hematol Blood Transfus. November, S 385 Modak K, Radhakrishnan V, Lama M, Kathrotiya M, Bhave JS, Kumar J et al (2018) Outcomes of consolidation with R-BEAM high dose chemoimmunotherapy and autologous hematopoietic cell rescue in high risk B-cell lymphoma: a tertiary care single center experience. Indian J Hematol Blood Transfus. November, S 385
3.
go back to reference Pai AA, Mani S, Panetta CJ, Ezhilpavai M, Stallon I, Balkrishnan B et al (2018) Pharmacokinetics of melphalan in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation. Indian J Hematol Blood Transfus. November, S 380 Pai AA, Mani S, Panetta CJ, Ezhilpavai M, Stallon I, Balkrishnan B et al (2018) Pharmacokinetics of melphalan in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation. Indian J Hematol Blood Transfus. November, S 380
5.
go back to reference Malhotra P, Yanamandra U, Khadwal A et al (2018) Autologous stem cell transplantation for multiple myeloma: single centre experience from North India. Indian J Hematol Blood Transfus 34(2):261–267CrossRefPubMed Malhotra P, Yanamandra U, Khadwal A et al (2018) Autologous stem cell transplantation for multiple myeloma: single centre experience from North India. Indian J Hematol Blood Transfus 34(2):261–267CrossRefPubMed
6.
go back to reference Naithani R, Dayal N, Rai R, Pathak S, Singh M (2018) Autologous hematopoietic stem cell transplantation for multiple myeloma in India. Indian J Hematol Blood Transfus 34(3):564–565CrossRefPubMedPubMedCentral Naithani R, Dayal N, Rai R, Pathak S, Singh M (2018) Autologous hematopoietic stem cell transplantation for multiple myeloma in India. Indian J Hematol Blood Transfus 34(3):564–565CrossRefPubMedPubMedCentral
7.
go back to reference Kapoor J, Soni P, Bhatia N, Agrawal N, Ahmed R, Mehta P et al (2018) Clinical profile and outcomes post allogenic hematopoietic stem cell transplantation in thalassemia patients: A single centre experience. Indian J Hematol Blood Transfus 50–51 Kapoor J, Soni P, Bhatia N, Agrawal N, Ahmed R, Mehta P et al (2018) Clinical profile and outcomes post allogenic hematopoietic stem cell transplantation in thalassemia patients: A single centre experience. Indian J Hematol Blood Transfus 50–51
9.
go back to reference Nikila R, Patel S, Sankaran M, Venkateswaran VS, Kesavan MR, Ramya U et al (2018) Balancing cure versus toxicity-haematopoietic stem cell transplantation for sickle cell anemia. Indian J Hematol Blood Transfus. November, S 200 Nikila R, Patel S, Sankaran M, Venkateswaran VS, Kesavan MR, Ramya U et al (2018) Balancing cure versus toxicity-haematopoietic stem cell transplantation for sickle cell anemia. Indian J Hematol Blood Transfus. November, S 200
10.
go back to reference Venkateswaran VS, Patel S, Sankaran M, Kesavan MR, Nikila R, Ramya U et al (2018) Treosulfan based conditioning regimen—reduced toxicity with excellent outcomes in children with primary immune deficiency. Indian J Hematol Blood Transfus. November, S 53 Venkateswaran VS, Patel S, Sankaran M, Kesavan MR, Nikila R, Ramya U et al (2018) Treosulfan based conditioning regimen—reduced toxicity with excellent outcomes in children with primary immune deficiency. Indian J Hematol Blood Transfus. November, S 53
11.
go back to reference Uppuluri R, Sivasankaran M, Patel S, Swaminathan VV, Ravichandran N, Ramanan KM et al (2018) Haematopoietic stem cell transplantation for children with inherited bone marrow failure syndromes: a single centre experience over 15 years from India. Indian J Hematol Blood Transfus. November, S 204 Uppuluri R, Sivasankaran M, Patel S, Swaminathan VV, Ravichandran N, Ramanan KM et al (2018) Haematopoietic stem cell transplantation for children with inherited bone marrow failure syndromes: a single centre experience over 15 years from India. Indian J Hematol Blood Transfus. November, S 204
12.
go back to reference Lahane CG, Apte S, Subramanian K, Phatale R, Roshan R (2018) Outcome of allogenic stem cell transplant in acute myeloid leukemia patients in a single centre over 7 yrs. Indian J Hematol Blood Transfus. November, S 378 Lahane CG, Apte S, Subramanian K, Phatale R, Roshan R (2018) Outcome of allogenic stem cell transplant in acute myeloid leukemia patients in a single centre over 7 yrs. Indian J Hematol Blood Transfus. November, S 378
13.
go back to reference Selvarajan S, Korula A, Fouzia NA, Abraham A, Srivastava A, Mathews V et al (2018) Outcomes of allogeneic hematopoietic stem cell transplantation for lymphomas: a single-centre experience. Indian J Hematol Blood Transfus. November, S 54 Selvarajan S, Korula A, Fouzia NA, Abraham A, Srivastava A, Mathews V et al (2018) Outcomes of allogeneic hematopoietic stem cell transplantation for lymphomas: a single-centre experience. Indian J Hematol Blood Transfus. November, S 54
14.
go back to reference Venkateswaran VS, Meena S, Shivani P, Keasvan MR, Nikila, Ramya U et al (2018) Donor lymphocyte infusion in children—efficacy in preventing graft rejection and relapse— experience from a tertiary referral centre in southern India. Indian J Hematol Blood Transfus. November, S 10 Venkateswaran VS, Meena S, Shivani P, Keasvan MR, Nikila, Ramya U et al (2018) Donor lymphocyte infusion in children—efficacy in preventing graft rejection and relapse— experience from a tertiary referral centre in southern India. Indian J Hematol Blood Transfus. November, S 10
15.
go back to reference Reba H, Korula A, Abraham A, Sindhuvi E, Lakshmi K, George B et al (2018) Impact of donor lymphocyte infusion in malignant and nonmalignant disease post-allogeneic stem cell transplant. Indian J Hematol Blood Transfus. November, S 383 Reba H, Korula A, Abraham A, Sindhuvi E, Lakshmi K, George B et al (2018) Impact of donor lymphocyte infusion in malignant and nonmalignant disease post-allogeneic stem cell transplant. Indian J Hematol Blood Transfus. November, S 383
16.
go back to reference Nagarajan R, Pai AA, Ravichandran AJ, Mani S, Mohanan E, Balakrishnan B et al (2018) GSTA1*B genotype influences intravenous busulfan pharmacokinetics and targeted dose adjustment in patients undergoing HSCT with busulfan based conditioning regimen. Indian J Hematol Blood Transfus. November, S 379 Nagarajan R, Pai AA, Ravichandran AJ, Mani S, Mohanan E, Balakrishnan B et al (2018) GSTA1*B genotype influences intravenous busulfan pharmacokinetics and targeted dose adjustment in patients undergoing HSCT with busulfan based conditioning regimen. Indian J Hematol Blood Transfus. November, S 379
17.
go back to reference Balasubramanian P, Pai A, Ezhilpavai M, Nagarajan R, Eunice SE, Kavitha ML et al (2018) Targeted iv busulfan-based conditioning regimen in patients with acute myelogenous leukemia undergoing allogeneic hematopoietic stem cell transplantation—a single centre experience. Indian J Hematol Blood Transfus 34–35 Balasubramanian P, Pai A, Ezhilpavai M, Nagarajan R, Eunice SE, Kavitha ML et al (2018) Targeted iv busulfan-based conditioning regimen in patients with acute myelogenous leukemia undergoing allogeneic hematopoietic stem cell transplantation—a single centre experience. Indian J Hematol Blood Transfus 34–35
18.
go back to reference Bharath Ram S, Bhat S, Nataraj KS, Badiger S, Kailasnath VP, Mallya P et al (2018) A prospective observational study of incidence of early cytomegalovirus reactivation and factors affecting it following allogeneic stem cell transplantation. Indian J Hematol Blood Transfus 205–206 Bharath Ram S, Bhat S, Nataraj KS, Badiger S, Kailasnath VP, Mallya P et al (2018) A prospective observational study of incidence of early cytomegalovirus reactivation and factors affecting it following allogeneic stem cell transplantation. Indian J Hematol Blood Transfus 205–206
19.
go back to reference Devasia AJ, Mammen S, Korula A, Abraham A, Fouzia NA et al (2018) A low incidence of cytomegalo virus infection following allogeneic hematopoietic stem cell transplantation despite a high seroprevalence. Indian J Hematol Blood Transfus 34(4):636–642CrossRefPubMed Devasia AJ, Mammen S, Korula A, Abraham A, Fouzia NA et al (2018) A low incidence of cytomegalo virus infection following allogeneic hematopoietic stem cell transplantation despite a high seroprevalence. Indian J Hematol Blood Transfus 34(4):636–642CrossRefPubMed
20.
go back to reference Suraj C, Korula A, Fouzia NA, Kavitha ML, Abraham A, Srivastava A, Mathews V et al (2018) Antifungal prophylaxis in acute GVHD post stem cell transplant—a single centre experience from Southern India. Indian J Hematol Blood Transfus. November, S 206 Suraj C, Korula A, Fouzia NA, Kavitha ML, Abraham A, Srivastava A, Mathews V et al (2018) Antifungal prophylaxis in acute GVHD post stem cell transplant—a single centre experience from Southern India. Indian J Hematol Blood Transfus. November, S 206
21.
go back to reference Upreti R, Sharma S, Satyanand K, Kapoor A, Asthana B, Venkatesan S et al (2018) Initial HSCT in non-HEPA filter AHU rooms: a single center experience. Indian J Hematol Blood Transfus. November, S 196 Upreti R, Sharma S, Satyanand K, Kapoor A, Asthana B, Venkatesan S et al (2018) Initial HSCT in non-HEPA filter AHU rooms: a single center experience. Indian J Hematol Blood Transfus. November, S 196
22.
go back to reference Kumar R, Kapoor R, Asthana B et al (2017) Single dose preemptive plerixafor for stem cell mobilization for ASCT after lenalidomide based therapy in multiple myeloma: impact in resource limited setting. Indian J Hematol Blood Transfus 33(4):463–469CrossRefPubMedPubMedCentral Kumar R, Kapoor R, Asthana B et al (2017) Single dose preemptive plerixafor for stem cell mobilization for ASCT after lenalidomide based therapy in multiple myeloma: impact in resource limited setting. Indian J Hematol Blood Transfus 33(4):463–469CrossRefPubMedPubMedCentral
23.
go back to reference Kumar K, Chezhian S, Prabhu D, Asokan L, Dharani B et al (2018) On demand plerixafor as a rescue strategy in healthy donors to achieve adequate stem cells—a pilot study. Indian J Hematol Blood Transfus. November, S 201 Kumar K, Chezhian S, Prabhu D, Asokan L, Dharani B et al (2018) On demand plerixafor as a rescue strategy in healthy donors to achieve adequate stem cells—a pilot study. Indian J Hematol Blood Transfus. November, S 201
24.
go back to reference Prabha L, Kumar K, Chezhian S (2018) Psychiatric illness in bone marrow transplantation patients. Indian J Hematol Blood Transfus. November, S 203 Prabha L, Kumar K, Chezhian S (2018) Psychiatric illness in bone marrow transplantation patients. Indian J Hematol Blood Transfus. November, S 203
25.
go back to reference Sathianathan P, George B (2018) Quality of life among allogenic hematopoietic stem cell transplant patients. Indian J Hematol Blood Transfus. November, S 386 Sathianathan P, George B (2018) Quality of life among allogenic hematopoietic stem cell transplant patients. Indian J Hematol Blood Transfus. November, S 386
26.
go back to reference Kesavan MR, Patel S, Sivasankaran M, Venkateswaran VS, Nikila R, Uppuluri R et al (2018) Normal growth and development post haematopoietic stem cell transplantation for thalassemia major using treosulfan based conditioning regimen—single centre long term study. Indian J Hematol Blood Transfus. November, S 49 Kesavan MR, Patel S, Sivasankaran M, Venkateswaran VS, Nikila R, Uppuluri R et al (2018) Normal growth and development post haematopoietic stem cell transplantation for thalassemia major using treosulfan based conditioning regimen—single centre long term study. Indian J Hematol Blood Transfus. November, S 49
27.
go back to reference Naithani R, Dayal N, Dixit G (2017) Single versus dual platform analysis for hematopoietic stem cell enumeration using ISHAGE protocol. Indian J Hematol Blood Transfus 33(3):370–374CrossRefPubMed Naithani R, Dayal N, Dixit G (2017) Single versus dual platform analysis for hematopoietic stem cell enumeration using ISHAGE protocol. Indian J Hematol Blood Transfus 33(3):370–374CrossRefPubMed
28.
go back to reference Mishra S, Mammen JJ, George B, Nair S, Kulkarni U, Matthews N et al (2018) A study to compare Haematopoietic Progenitor Cell (HPC) determined on the Sysmex XN-9000 with flowcytometric CD34 count in peripheral blood and in the harvested peripheral blood stem cell graft from autologous and allogenic donors. Indian J Hematol Blood Transfus. November, S 9 Mishra S, Mammen JJ, George B, Nair S, Kulkarni U, Matthews N et al (2018) A study to compare Haematopoietic Progenitor Cell (HPC) determined on the Sysmex XN-9000 with flowcytometric CD34 count in peripheral blood and in the harvested peripheral blood stem cell graft from autologous and allogenic donors. Indian J Hematol Blood Transfus. November, S 9
29.
go back to reference Vani S, Devi AS, Chandramouleeswaran N, Meganathan V, Kumar NM, Yogesh NK et al (2018) Next generation sequencing: an accurate and unambiguous method for HLA whole genome typing. Indian J Hematol Blood Transfus. November, S 195 Vani S, Devi AS, Chandramouleeswaran N, Meganathan V, Kumar NM, Yogesh NK et al (2018) Next generation sequencing: an accurate and unambiguous method for HLA whole genome typing. Indian J Hematol Blood Transfus. November, S 195
30.
go back to reference Srinivasan G, Eswari S, Sumithra S, Shaji RV, Edison ES (2018) Comparison of DNA based chimerism analysis with direct amplification using whole blood. Indian J Hematol Blood Transfus. November, S 202 Srinivasan G, Eswari S, Sumithra S, Shaji RV, Edison ES (2018) Comparison of DNA based chimerism analysis with direct amplification using whole blood. Indian J Hematol Blood Transfus. November, S 202
Metadata
Title
Highlights of Abstracts on Hematopoietic Stem Cell Transplant in Annual Conference of ISHBT 2018
Authors
Preethi Jeyaraman
Rahul Naithani
Publication date
01-01-2019
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 1/2019
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-018-01067-5

Other articles of this Issue 1/2019

Indian Journal of Hematology and Blood Transfusion 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine